Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $101.4650 (-1.78%) ($100.0200 - $107.6500) on Mon. Mar. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.65% (three month average) | RSI | 55 | Latest Price | $101.4650(-1.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.7% a day on average for past five trading days. | Weekly Trend | LGND advances 2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(61%) IWO(61%) IWM(60%) IWC(57%) IWN(57%) | Factors Impacting LGND price | LGND will decline at least -1.825% in a week (0% probabilities). VIXM(-26%) UUP(-21%) VXX(-17%) TBT(-6%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.825% (StdDev 3.65%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $104.49 | 5 Day Moving Average | $103.67(-2.13%) | 10 Day Moving Average | $101.52(-0.05%) | 20 Day Moving Average | $104.49(-2.9%) | To recent high | -37.7% | To recent low | 6.4% | Market Cap | $1.631b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |